Miyako Capital logo

Miyako Capital

Asia, Kyoto, Japan, Kyoto

Description

Venture capital that manages Kyoto University 2nd Venture Fund (KUVF).

Investor Profile

Miyako Capital has made 14 investments, with 5 in the past 12 months and 21% as lead.

Stage Focus

  • Seed (43%)
  • Series C (29%)
  • Series A (21%)
  • Series B (7%)

Country Focus

  • Japan (71%)
  • United States (21%)
  • United Kingdom (7%)

Industry Focus

  • Information Technology
  • Software
  • Biotechnology
  • Health Care
  • Medical
  • Artificial Intelligence (Ai)
  • Generative Ai
  • Semiconductor
  • 3d Technology
  • Augmented Reality
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Miyako Capital frequently co-invest with?

SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
ANRI
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Global Brain Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
500 Global
North America, California, United States, San Francisco
Co-Investments: 2
JAFCO
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
KDDI
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 1
Lux Capital
North America, New York, United States, New York
Co-Investments: 2
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Miyako Capital often collaborate with?

JD
North America, California, United States, Palo Alto
Shared Deals: 1
CD
North America, New York, United States, New York
Shared Deals: 1
RH
North America, District of Columbia, United States, Washington
Shared Deals: 1

What are some of recent deals done by Miyako Capital?

Oishii

Jersey City, New Jersey, United States

Oishii is a vertical farming company that grows fruit in an indoor vertical farm at commercial scale.

AgricultureAgTechFarming
Series BDec 17, 2024
Amount Raised: $19,535,078
Peds3

Tokyo, Tokyo, Japan

Peds3 is a digital healthcare platform that specializes in the development of pediatric medicine and maternal and child health fields.

Child CareHealth CareMedical
SeedOct 2, 2024
Amount Raised: $750,451
Innovative Space Carrier

Tokyo, Tokyo, Japan

Innovative Space Carrier is a aerospace company that offers space transportation systems, planning, drafting and technology strategies.

AerospaceConsultingTransportation
SeedSep 10, 2024
Amount Raised: $2,531,162
Sakana AI

Tokyo, Tokyo, Japan

Sakana AI is an IT firm that develops an AI-based model to generate text, images, video, code, and multimedia.

Artificial Intelligence (AI)Generative AIInformation Technology
Series ASep 4, 2024
Amount Raised: $214,000,000
Orange

Akasaka, Tokyo, Japan

Orange is a developer of a variety of deep-learning models with a focus on computer vision and natural language processing for comics.

Artificial Intelligence (AI)Information TechnologyMachine Learning
SeedMay 6, 2024
Amount Raised: $18,975,394
Sakana AI

Tokyo, Tokyo, Japan

Sakana AI creates a new kind of foundation model based on nature-inspired intelligence.

Artificial Intelligence (AI)Generative AIInformation Technology
SeedJan 16, 2024
Amount Raised: $30,000,000
Helpfeel

Kyoto, Kyoto, Japan

Nota develops an app for seriously easy sharing of screen caps and GIFs and Scrapbox, a new style of note-taking for teams.

CollaborationDeveloper ToolsMobileMobile Apps
Series CSep 5, 2022
Amount Raised: $4,272,424
Viage Therapeutics

San Francisco, California, United States

Viage Therapeutics is a biotech company that develops therapeutics that stimulates the central nervous system via the gut-brain axis.

BiotechnologyClinical TrialsMedical
SeedJan 6, 2022
Amount Raised: $10,000,000
VividQ

Cambridge, Cambridgeshire, United Kingdom

VividQ has created the next generation of immersive experience through their computational holographic display technology.

3D TechnologyAugmented RealitySoftwareVirtual Reality
SeedJul 1, 2021
Amount Raised: $15,134,942
VLP Therapeutics

Gaithersburg, Maryland, United States

VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.

BiotechnologyHealth CareMedicalMedical Device
Series AMar 15, 2021
Amount Raised: $16,000,000